STERIS STE · NYSE
$252.29 -0.72% (-$1.83)
Summary
72 / 100 · Bulios Score
What speaks for it
- Earnings per share grew by 95% a year over the last 3 years.
- It has raised its dividend 15 years in a row and pays out only 30% of profit.
- Out of every 100 USD of revenue, 13 USD is left as net profit.
- It holds more cash than debt: $531.1M against $243.1M.
What to watch
- The share price is above the Bulios Fair Price.
- Earnings per share swing sharply from year to year.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 29.7 USD for 1 USD of yearly profit. Over the last five years it was 80.0 USD on average.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 14% a year over 5 years. Over the last 3 years it grew by 9.4% a year. For the next fiscal year analysts expect revenue to grow by 7.4%. Earnings per share grew by 95% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 USD of revenue goes
- Cost of sales 55 USD
- Research and development 1.9 USD
- Sales and administration 24 USD
- Taxes and other 5.5 USD
- Net profit 13 USD
Net profit, industry median (Medical - Specialties) 9.0 USD
Out of every 100 USD of revenue, 13 USD is left as net profit.
Profitability in detailIs it financially healthy?
YesIt could repay all its debt from a single year of free cash flow. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
Small, safe- Yield
- 1.02%
- Paid out of profit
- 30%
- Raised in a row
- 15 years
You receive $2.58 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 12
- Hold 2
- Sell 0
Today's price within the analysts' price targets
The average target of $271.33 is 7.5% above today's price. 86% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2026By product
- Product 52%
- Service 48%
By region
- UNITED STATES 73%
- Other foreign locations 25%
- IRELAND 1.8%
Product brings in 52% of revenue. Service grew fastest, by 9.1% a year.
Segments in detail